STOCK TITAN

Red White & Bloom Brands Provides Update on Financial Statement Filings

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Red White & Bloom Brands Inc. (RWBYF) announced the appointment of Macias Gini & O’Connell LLP as its new auditor, succeeding MNP LLP. This change comes as the company continues to work on finalizing its audited annual financial statements for the fiscal year ended December 31, 2020. The delay was caused by the previous auditor's inability to complete necessary procedures by the filing deadline. RWB is committed to meeting regulatory requirements and will issue bi-weekly status reports during this process.

Positive
  • Engaged a new auditor, MGO, to expedite the audit process.
  • No material issues reported with the auditor's review.
Negative
  • Delay in filing audited financial statements due to prior auditor's inefficiency.

TORONTO, June 15, 2021 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB and OTCQX: RWBYF) (“RWB” or the “Company”), a multi-state cannabis operator and house of premium brands, is providing an update with respect to the filing of the Company’s audited annual financial statements for the year ended December 31, 2020, the related management’s discussion and analysis, related CEO and CFO certificates and annual information form for the year ended December 31, 2020 (collectively, the “Documents”), further to its May 31, 2021 update.

As of Friday, June 11, 2021, the Company has engaged Macias Gini & O’Connell LLP (“MGO”) as the successor auditor to replace MNP LLP (“MNP”). In connection with the appointment, the Company will be concurrently filing its change of auditor package with the securities commissions to reflect the appointment of MGO as its auditor.

The Company and MGO, with the full support of MNP are working towards completing the audit and filing the Documents.

The Company is not aware of any material issue with the auditor’s review. The Company continues to work diligently and expeditiously with its auditor to finalize the Documents. The Company confirms that it intends to satisfy the provisions of NP 12- 203 and will continue to issue bi-weekly default status reports for so long as it remains in default of the annual filing requirements.

As previously disclosed in the May 31, 2021 update, the delay in completing the filing of the Documents was due to the Company’s auditor not completing its audit procedures in advance of the filing deadline.

About Red White & Bloom Brands Inc.

The Company is positioning itself to be one of the top three multi-state cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on the major US markets, including Michigan, Illinois, Massachusetts, Arizona and California with respect to cannabis, and the US and internationally for hemp-based CBD products.

For more information about Red White & Bloom Brands Inc., please contact:

Brad Rogers, CEO and Chairman
604-687-2038

Tyler Troup, Managing Director
Circadian Group IR
IR@RedWhiteBloom.com

Visit us on the web: www.RedWhiteBloom.com

Follow us on social media:
Twitter: @rwbbrands
Facebook: @redwhitebloombrands
Instagram: @redwhitebloombrands

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

FORWARD LOOKING INFORMATION

This press release contains forward-looking statements and information that are based on the beliefs of management and reflect the Company’s current expectations.  When used in this press release, the words “estimate”, “project”, “belief”, “anticipate”, “intend”, “expect”, “plan”, “predict”, “may” or “should” and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information.  There is no assurance that these transactions will yield results in line with management expectations. Such statements and information reflect the current view of the Company with respect to risks and uncertainties that may cause actual results to differ materially from those contemplated in those forward-looking statements and information.

By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.  Such factors include, among others, the following risks: risks associated with the implementation of the Company’s business plan and matters relating thereto, risks associated with the cannabis industry, competition, regulatory change, the need for additional financing, reliance on key personnel, market size, and the volatility of the Company’s common share price and volume.  Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made, and the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change.  Investors are cautioned against attributing undue certainty to forward-looking statements.

There are a number of important factors that could cause the Company’s actual results to differ materially from those indicated or implied by forward-looking statements and information.  Such factors include, among others, risks related to the Company’s proposed business, such as failure of the business strategy and government regulation; risks related to the Company’s operations, such as additional financing requirements and access to capital, reliance on key and qualified personnel, insurance, competition, intellectual property and reliable supply chains; risks related to the Company and its business generally; risks related to regulatory approvals. The Company cautions that the foregoing list of material factors is not exhaustive. When relying on the Company’s forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. The Company has assumed a certain progression, which may not be realized.  It has also assumed that the material factors referred to in the previous paragraph will not cause such forward-looking statements and information to differ materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors. While the Company may elect to, it does not undertake to update this information at any particular time.

THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS PRESS RELEASE REPRESENTS THE EXPECTATIONS OF THE COMPANY AS OF THE DATE OF THIS PRESS RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE.  READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS INFORMATION AS OF ANY OTHER DATE. WHILE THE COMPANY MAY ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY PARTICULAR TIME EXCEPT AS REQUIRED IN ACCORDANCE WITH APPLICABLE LAWS.


FAQ

What new auditor has Red White & Bloom Brands Inc. appointed?

Red White & Bloom Brands Inc. has appointed Macias Gini & O’Connell LLP as its new auditor.

Why is Red White & Bloom Brands Inc. delaying its financial statement filings?

The delay is due to the previous auditor not completing the required procedures by the filing deadline.

What is the stock symbol for Red White & Bloom Brands Inc.?

The stock symbol for Red White & Bloom Brands Inc. is RWBYF.

When did Red White & Bloom Brands Inc. announce the delay in its financial filings?

The announcement about the delay was made on June 15, 2021.

Is Red White & Bloom Brands Inc. compliant with its filing requirements?

The company intends to comply with filing requirements and will provide bi-weekly reports while in default.

Red White & Bloom Brands Inc.

OTC:RWBYF

RWBYF Rankings

RWBYF Latest News

RWBYF Stock Data

13.71M
432.30M
7.93%
0.07%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Canada
Vancouver